Clínica Médica
Breve atualização de diretriz NICE sobre tratamento de Covid-19.
24 Mai, 2022 | 11:54hCOVID-19 rapid guideline: managing COVID-19 – National Institute for Health and Care Excellence
Estudo randomizado | Oxigênio nasal de alto fluxo não é benéfico para pacientes com pneumonia por Covid-19 e hipoxemia leve.
24 Mai, 2022 | 11:51hRevisão | Hipotireoidismo.
24 Mai, 2022 | 11:49hHypothyroidism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)
Infográfico: Hypothyroidism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)
OMS | Surto de varíola dos macacos em muitos países não endêmicos.
24 Mai, 2022 | 11:46hMulti-country monkeypox outbreak in non-endemic countries – World Health Organization
Monkeypox goes global: why scientists are on alert – Nature
Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT
Monkeypox: Time to worry or one to ignore? – BBC
UK, Spain, Portugal report more monkeypox cases – CIDRAP
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
Comentário no Twitter
The WHO has started to report data on the monkeypox outbreak: https://t.co/e3Q23sllvX pic.twitter.com/3WKqj79eLy
— Max Roser (@MaxCRoser) May 22, 2022
Revisão sistemática | Antieméticos profiláticos para adultos em uso de opioides intravenosos no ambiente de cuidado agudo.
24 Mai, 2022 | 11:38hPrevenção de demência: quais são as evidências?
24 Mai, 2022 | 11:37hPreventing dementia: what’s the evidence? – Evidently Cochrane
Medicamentos para agitação em pessoas com demência: benefícios e riscos.
24 Mai, 2022 | 11:36hDrugs for agitation in people with dementia: benefits and risks – Evidently Cochrane
Estudo original: Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia – Cochrane Library
Comentário no Twitter (fio – clique para saber mais)
New blog for #DementiaActionWeek: https://t.co/UT1sdwNZRv @CharSquires & @jamie_garr look at the @CochraneDCIG evidence on drugs used to treat agitation & psychosis in people with #dementia & reflect on what doctors & families may want to consider when making treatment decisions pic.twitter.com/Ei7njr3ynL
— Cochrane UK (@CochraneUK) May 20, 2022
Estudo de coorte | Associação entre intensidade do tratamento com hormônio da tireoide e mortalidade cardiovascular.
24 Mai, 2022 | 11:35hComentários:
Thyroid Hormone Treatment Intensity and Cardiovascular Mortality – American College of Cardiology
Thyroid Hormone Treatment Intensity May Be Modifiable Risk Factor for CV Mortality – HCP Live
Comentário no Twitter
In this cohort study of US Veterans on thyroid hormone therapy, both exogenous hyperthyroidism and hypothyroidism contributed to the increased risk of cardiovascular mortality after adjusting for demographic and traditional cardiovascular risk factors. https://t.co/NO4776Ia4m
— JAMA Network Open (@JAMANetworkOpen) May 12, 2022
Revisão | Asma alérgica é um fator de risco para doenças cardiovasculares.
24 Mai, 2022 | 11:26hAllergic asthma is a risk factor for human cardiovascular diseases – Nature Cardiovascular Research
Comentário no Twitter
A Review in @NatureCVR discusses how asthma and allied allergic conditions may contribute to the prevalence, incidence and progression of cardiovascular diseases and vice versa. https://t.co/6kRj9LvOfa pic.twitter.com/Ydq8X2k1rY
— Nature Portfolio (@NaturePortfolio) May 18, 2022